The vulnerability, referred to as Branch Privilege Injection (BPI), "can be exploited to misuse the prediction calculations of the CPU (central processing unit) in order to gain unauthorized access to ...

Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone ® 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple ...

The trials are testing the company’s 100-mcg orally disintegrating tablet MM120, which received FDA Breakthrough Therapy based on results from a phase 2B trial in GAD. In that study, one dose of ...